MARLTON, N.J. & LONG BEACH, Calif.–(BUSINESS WIRE)–CNS Network (“CNS”) and Hassman Research Institute (“HRI”) have completed a strategic merger to form Apex Innovative Sciences, Inc. (“Apex” or the “Company”). The combination represents the...
– Significant tumor regression observed with onvansertib in combination with standard-of-care paclitaxel in models of p53-mutated TNBC – Onvansertib preclinical data provides rationale for clinical trial targeting the 80% of TNBC that harbors the p53...
Management will host its third quarter 2019 conference call on Monday, November 11, 2019 to provide a corporate update and review the Company’s poster presentations from SITC HOLON, Israel, Oct. 2, 2019 /PRNewswire/ — October 2, 2019 – Compugen...
Study evaluates clinical utility of 68Ga THP-PSMA PET/CT imaging in men with newly diagnosed and recurrent prostate cancer LONDON and BOSTON, Oct. 2, 2019 /PRNewswire/ — Theragnostics, which is developing innovative radiopharmaceuticals to improve cancer...
CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the “Company”), a late stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, announced today FDA clearance to initiate enrollment in the...
Email
Text